Merck & Co. is ending development of its two experimental COVID-19 vaccines, after early data showed they could not produce immune responses to the virus, the company announced Monday.
Why it matters: The news leaves one of the top pharmaceutical companies out of the running for producing a vaccine, as demand for the inoculation is outstripping supply.